Clinical trial empowers women to choose how to deliver big babies

US FDA Extends Review Of AstraZeneca’s Experimental Breast Cancer Pill

AstraZeneca said on Wednesday the U.S. Food and Drug Administration has extended ⁠the decision deadline for the drugmaker's experimental breast cancer pill camizestrant to...

Cesarean Birth Raises Postpartum Psychiatric Risk

Cesarean deliveries, whether planned or unplanned, are associated with an increased risk for new postpartum psychiatric conditions compared with spontaneous vaginal births.

Some Midwives Break the Law To Assist With Home Births

Midwives are helping more Georgia families with home births even though the practice is illegal, as demand rises and lawmakers clash over whether to legalize and regulate it.

In-Office Nitrous Oxide Linked to Fewer OR Ob/Gyn Procedures

In addition to reducing OR burden and its accompanying costs, offering nitrous oxide for in-office procedures can be easier for patients.

Possible Shift to Misoprostol Only for Medication Abortion?

If tighter limits on mifepristone take effect, one immediate shift would be toward misoprostol-only protocols.

US Supreme Court Extends Pause on Decision Narrowing Abortion Pill Access

The U.S. Supreme Court on Monday extended a pause on a ruling that would curb the abortion pill mifepristone from being ⁠prescribed through telemedicine and dispensed...

Treatment of Vulvodynia Differs by Race and Ethnicity

The reasons for the disparities are not clear, but they point to the complexity of the diagnosis and the different ways patients may describe pain and symptoms.

Maternal Endometriosis Tied to Birth Defects

Endometriosis in mothers is associated with an increased risk for congenital anomalies in their infants.

Unpacking Emerging Evidence and Addressing Complex Questions in HER2+ Early Breast Cancer Office Hours

Unpacking Emerging Evidence and Addressing Complex Questions in HER2+ Early Breast Cancer Office Hours

Scaling Excellence in HER2-Low and -Ultralow Breast Cancer: Real-World Strategies for Testing and Treatment Optimization

Scaling Excellence in HER2-Low and -Ultralow Breast Cancer: Real-World Strategies for Testing and Treatment Optimization

Beyond CLEOPATRA: Integrating Evolving Frontline Maintenance Strategies in HER2+ Metastatic Breast Cancer

Beyond CLEOPATRA: Integrating Evolving Frontline Maintenance Strategies in HER2+ Metastatic Breast Cancer

Facing Resistance: Novel Approaches for Endocrine-Resistant HR+/HER2- Breast Cancer

Facing Resistance: Novel Approaches for Endocrine-Resistant HR+/HER2- Breast Cancer

Emerging Evidence and Expert Perspectives: Evolving Treatment Strategies in HER2+ Early Breast Cancer

Emerging Evidence and Expert Perspectives: Evolving Treatment Strategies in HER2+ Early Breast Cancer

Powering Up First-Line Treatment in Triple-Negative Breast Cancer: How Antibody-Drug Conjugates and Immune Checkpoint Inhibitors Are Changing the Game

Powering Up First-Line Treatment in Triple-Negative Breast Cancer: How Antibody-Drug Conjugates and Immune Checkpoint Inhibitors Are Changing the Game

ACOG: American College of Obstetricians and Gynecologists

Platinum-Resistant Ovarian Cancer (PROC) Office Hours: Translating Clinical Trials Into Clinical Practice for PROC

Platinum-Resistant Ovarian Cancer (PROC) Office Hours: Translating Clinical Trials Into Clinical Practice for PROC